Skip to main content
HANDOK Inc. logo

HANDOK Inc. — Investor Relations & Filings

Ticker · 002390 ISIN · KR7002390003 KO Manufacturing
Open in API
Filings indexed 422 across all filing types
Latest filing 2024-04-22 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 002390

About HANDOK Inc.

https://www.handok.co.kr/en/

Handok Inc. is a total healthcare company that develops, manufactures, and distributes a comprehensive range of healthcare solutions. Its portfolio includes prescription drugs, general medicine, medical devices, and in-vitro diagnostics. The company's core business focuses on therapeutic areas such as diabetes, cardiovascular and musculoskeletal diseases, and psychoneurotic disorders, in addition to human vaccines. Positioning itself as a "Health Innovator," Handok provides products and services aimed at prevention, diagnosis, and health management. The company collaborates with global enterprises and manages the entire value chain from sourcing and development to commercialization.

Recent filings

Filing Released Lang Actions
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a 'Correction Report' (정정신고) regarding the granting of stock options (주식매수선택권 부여에 관한 신고). It details changes to previously reported stock option grants, including cancellations and adjustments to the number of shares. In the context of Korean regulatory filings (DART), reports concerning stock options, capital changes, or share-related disclosures that do not fit into specific categories like 'Director's Dealing' or 'Share Issue' are classified under general regulatory filings.
2024-04-22 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a 'Correction Report' (정정신고) regarding a previously filed 'Stock Option Grant' (주식매수선택권 부여에 관한 신고). It details changes to the number of shares and the list of grantees for stock options. In the context of financial filings, announcements regarding the issuance, modification, or cancellation of stock options or capital-related instruments are classified as 'Share Issue/Capital Change' (SHA).
2024-04-22 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) and specifically a '정정신고' (Amendment Report). It details changes to previously reported stock option grants, including the cancellation of certain grants. In the context of financial filings, reports regarding stock options, capital changes, or equity-based compensation that do not fit into specific categories like 'Director's Dealing' or 'Remuneration' are classified under general regulatory filings. Since this is a formal amendment to a previous regulatory disclosure, it falls under the RNS category.
2024-04-22 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) and specifically a '정정신고' (Correction Report). It details changes to previously reported stock option grants, including adjustments to the number of recipients and the number of shares. This type of disclosure regarding stock options and capital-related changes falls under the category of Regulatory Filings (RNS) as it is a specific corporate announcement required by the Korea Exchange/Financial Services Commission that does not fit into more specific categories like 'Director's Dealing' (which is for personal trades) or 'Share Issue' (which is for new capital issuance).
2024-04-22 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a regulatory filing titled '주식매수선택권 부여에 관한 신고' (Report on Granting of Stock Options) and is a '정정신고' (Correction Report) regarding previously granted stock options. This type of filing relates to corporate capital structure and equity-based compensation, which falls under the category of Regulatory Filings (RNS) as it is a specific corporate disclosure required by the financial authorities (Financial Services Commission/Korea Exchange) that does not fit into more specific categories like DIRS (Director's Dealing) or SHA (Share Issue).
2024-04-22 Korean
[기재정정]주식매수선택권부여에관한신고
Share Issue/Capital Change Classification · 100% confidence The document is a 'Correction Report' (정정신고) regarding a previously filed 'Stock Option Grant' (주식매수선택권 부여에 관한 신고). It details specific changes to the number of shares and the list of grantees for stock options. In the context of corporate filings, announcements regarding share-based compensation, capital changes, or adjustments to equity-linked instruments are classified under 'Share Issue/Capital Change' (SHA) as they represent changes to the company's capital structure and equity obligations.
2024-04-22 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.